Business
Galmed Announces Digital Asset Management Strategy to Enhance Capital Efficiency and Drive Shareholder Value
Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for the treatment of liver, cardiometabolic diseases and GI oncological indications, today announced that its Board of Directors has approved a digital asset management strategy as part of a new treasury investment policy and capital allocation initiative. To this end, the Board established a Crypto Committee of the Board, which is evaluating and, if appropriate, will oversee the im
About this update from Galmed Pharmaceuticals Ltd.
[{"type":"list","items":[{"val":[{"type":"text","content":"An amendment to the Company's Articles of Association to increase the authorized share capital from 50,000,000 ordinary shares to 900,000,000 ordinary shares was approved at the Company's Special General Meeting of shareholders held on August 15, 2025","length":259,"tagName":"p"}]},{"val":[{"type":"text","content":"The Company is initially planning to invest up to $10M representing approximately 50% of its current cash balance to be deployed in execution of an active digital asset management strategy which may include covered call options, staking, lending, and yield-generating protocols","length":282,"tagName":"p"}]},{"val":[{"type":"text","content":"Galmed is in the process of engaging Tectona Ltd. (TASE: TECT), a specialized crypto treasury management service provider, to advise and implement digital asset strategy by Galmed","length":184,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":725,"olType":false},{"type":"text","content":"TEL AVIV, Israel, Aug. 25, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for the treatment of liver, cardiometabolic diseases and GI oncological indications, today announced that its Board of Directors has approved a digital asset management strategy as part of a new treasury investment policy and capital allocation initiative. To this end, the Board established a Crypto Committee of the Board, which is evaluating and, if appropriate, will oversee the implementation of any crypto investing related activities, including a potential allocation of up to 50% of the Company's cash reserves to be used for the purchase of digital assets, which is currently about $10 million.","length":790,"tagName":"p"},{"type":"image","alt":"Galmed Pharmaceuticals Logo","displaySize":"","headline":null,"caption":"Galmed Pharmaceuticals Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":95,"url":"https://media.zenfs.com/en/prnewswire.com/0bd7ffdcf08721d90a3bcb5658c1e61e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/rkpv_HpbOjVKPN_v6KG17Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE2NztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/0bd7ffdcf08721d90a3bcb5658c1e61e","width":400,"height":95}}},{"type":"text...